N@N

Leonid Timashev Maintained (AXSM) at Buy with Increased Target to $130 on, Jun 5th, 2024

Leonid Timashev of RBC Capital, Maintained "Axsome Therapeutics, Inc." (AXSM) at Buy with Increased Target from $127 to $130 on, Jun 5th, 2024.

Leonid has made no other calls on AXSM in the last 4 months.

There are 9 other peers that have a rating on AXSM. Out of the 9 peers that are also analyzing AXSM, 0 agree with Leonid's Rating of Hold.

These are the ratings of the 9 analyists that currently disagree with Leonid

---

• Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Decreased Target to $106 on, Wednesday, May 8th, 2024
• Joel Beatty of "Baird" Maintained at Buy with Increased Target to $112 on, Tuesday, May 7th, 2024
• Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $190 on, Tuesday, May 7th, 2024
• David Hoang of "Citigroup" Maintained at Strong Buy with Decreased Target to $125 on, Tuesday, May 7th, 2024
• Vikram Purohit of "Morgan Stanley" Upgraded from Hold to Buy and Increased Target to $115 on, Monday, April 29th, 2024
• Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $107 on, Wednesday, April 10th, 2024
• Joon Lee of "Truist Securities" Maintained at Strong Buy and Held Target at $150 on, Tuesday, March 26th, 2024
• Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Increased Target to $125 on, Wednesday, February 21st, 2024
• Ashwani Verma of "UBS" Initiated at Strong Buy and Held Target at $111 on, Tuesday, February 6th, 2024

Contributing Sources

---